The Market In 5 Minutes 5/22/2017

Posted Leave a commentPosted in Market

While some investors fear the uncertainty of possible Trump impeachment proceedings, others seem to be realizing that the possibility of a Mike Pence presidency could be the best possible news for investors: Now that most companies have reported first-quarter earnings, Benzinga took a look at some of the largest, most popular tech companies in the […]

Wall Street’s M&A Chatter From May 18: B. Riley-Wunderlich, Lowe’s-Maintenance Supply, Energy Transfer-PennTex Midstream Partners

Posted Leave a commentPosted in Market

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday, May 18, 2017. Energy Transfer Partners Makes Tender Offer To Purchase PennTex Midstream Partners for $20/Unit Cash The Tender Offer: Energy Transfer Partners LP ETP announced a tender offer to purchase all of the outstanding common units representing limited partner […]

8 Stocks To Watch For May 19, 2017

Posted Leave a commentPosted in Market

Some of the stocks that may grab investor focus today are: Wall Street expects Foot Locker, Inc. FL to report quarterly earnings at $1.38 per share on revenue of $2.02 billion before the opening bell. Foot Locker shares rose 0.48 percent to $70.79 in after-hours trading. Ross Stores, Inc. ROST posted better-than-expected profit for its […]

The Market In 5 Minutes 5/19/2017

Posted Leave a commentPosted in Market

Not yet a year into his presidency, Brazilian President Michel Temer is facing a major bribery scandal that has sent Brazilian stocks tumbling: Twitter Inc (TWTR) shares jumped 2 percent after cofounder Biz Stone announced he is returning to work for the company full-time. Why are investors so optimistic about Stone’s return? Here’s a look at […]

18 Biggest Mid-Day Losers For Thursday

Posted Leave a commentPosted in Uncategorized

Ascena Retail Group Inc ASNA 30.14% shares dipped 37.8 percent to $1.75 after the company lowered its Q3 and FY17 guidance. Endologix, Inc. ELGX 35.96% shares dropped 35 percent to $4.38 after the company issued an update on Nellix System US regulatory status. Following meeting with the FDA, Endologix will seek US approval by conducting […]